Tuesday - January 20, 2026

Riverhouse Hospitality Celebrates Milestones, Maritime Legacy, and a Continued Commitment to Preserving Connecticut’s Historic Experiences

Riverhouse Hospitality, one of Connecticut’s premier hospitality and event groups, is celebrating a series of major milestones that underscore its long-standing commitment to quality, craftsmanship, and the preservation of historic venues across the state. The company’s latest expansion, Riverhouse Cruises, … Continue reading

All the Presidents’ Dates Brings American History to Life – One Date at a Time

A uniquely engaging reference that transforms presidential history into an accessible, date-driven journey. By organizing key moments, births, marriages, terms in office, and pivotal milestones. All the Presidents’ Dates reveals patterns and connections across administrations, inviting readers to discover American … Continue reading

Parkinson’s Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Parkinson’s Disease pipeline constitutes 80+ key companies continuously working towards developing 100+ Parkinson’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Hearing Loss Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Sensorion, Fennec Pharma, Sound Pharma, Decibel Therapeutics, Akouos

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hearing Loss pipeline constitutes 30+ key companies continuously working towards developing 35+ Hearing Loss treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Sickle Cell Disease Market Reaches USD 650 Million in 2023, Gene Therapies and Novel Pipelines Set to Transform Growth Through 2034, estimates DelveInsight

Sickle Cell Disease Market Sickle Cell Disease market players active in the domain include Cellectis, Sana Biotechnology, Global Blood Therapeutics, CSL Behring, Pfizer, Aruvant Sciences, Graphite Bio, Novartis, Agios Pharmaceuticals, Forma Therapeutics, Vertex Pharmaceuticals, Alfasigma, Novo Nordisk, bluebird bio, ExCellThera, … Continue reading

Waldenstrom Macroglobulinemia Market Set for Steady Growth Through 2034, Driven by Emerging Therapies and Rising Diagnosis Rates, estimates DelveInsight

Waldenstrom Macroglobulinemia Market Waldenstrom Macroglobulinemia companies include AbbVie, Cellectar Biosciences, TG Therapeutics, Eli Lilly, Celgene, AstraZeneca, ADC Therapeutics, Amgen, Merck, Onyx Therapeutics, BeiGene, GSK, InnoCare Pharma, Millennium Pharma, Janssen, among others. Waldenström macroglobulinemia (WM) is a rare, indolent form of … Continue reading